Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 32,000 FULC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 32,000 | n/a |
| Jun 11, 2026 | Voyager Therapeutics, Inc. (VYGR) | Grant/Award | 30,000 | n/a |
| Jun 30, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 36,000 | n/a |
| Jun 4, 2025 | Voyager Therapeutics, Inc. (VYGR) | Grant/Award | 24,000 | n/a |
| Dec 12, 2024 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Disposition to Issuer | 1 | $0.01 |
| Oct 28, 2024 | PIERIS PHARMACEUTICALS, INC. (PIRS) | Purchase | 1 | $1.00 |
| Jun 18, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |
| Jun 7, 2024 | Voyager Therapeutics, Inc. (VYGR) | Grant/Award | 24,000 | n/a |
| Jan 24, 2024 | Orchard Therapeutics plc (ORTX) | Disposition to Issuer | 44,391 | n/a |
| Jun 29, 2023 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 30,000 | n/a |